Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Headaches Clinical Trials

A listing of Headaches medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (21) clinical trials

Have you suffered from at least 2 migraines per month for at least 3 months or more? Are you female, at least 18 years of age? Have you suffered from headaches during your last 2 or 3 menstrual cycles? If so, you may qualify to participate in a research study ...

Phase

Do you suffer from migraine headaches? If so, you may qualify to participate in a research study being conducted locally. People who suffer with migraine headaches may have headaches with intense throbbing in one area of the head that is sometimes accompanied by nausea, vomiting, and extreme sensitivity to light ...

Phase

To evaluate the effect of a study drug compared to placebo on the change from baseline in monthly migraine days, in subjects with chronic migraine

Phase

This study is to evaluate the effectiveness and safety of an investigational medication versus a placebo for the treatment of a single tension headache. It will involve keeping an electronic diary for 1-2 months and making 4 visits to the study clinic.

Phase

To evaluate the efficacy of repeat doses of ALD403 administered intravenously (IV) compared to placebo in patients with Frequent Episodic Migraine (FEM).

Phase

Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Phase

To assess the single dose PK of galcanezumab administered via subcutaneous injection in a population of pediatric patients aged 6 to 17 years with migraine

Phase

This is a placebo controlled trial to test the efficacy and safety of AMG 301 in the prevention of episodic and chronic migraine. The treatment period is 12 weeks and the total study duration is 35 weeks.

Phase

A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH

This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of fremanezumab in adult patients aged 18 to 70 years, inclusive, for the prevention of PPTH. Patients will provide written informed consent and during study visits they will use an electronic diary application daily, ...

Phase

Psilocybin for the Treatment of Migraine Headache

The purpose of this study is to investigate the effects of oral psilocybin in migraine headache. Subjects will each receive a dose of placebo and a dose of psilocybin approximately 14 days apart. Subjects will be randomized to the order of treatment and they will be randomized to receive either ...

Phase